Overlap syndrome SLE – ANCA associated vasculitis

Czech version

Authors: Martina Skácelová ¹; Pavel Horák ¹; Jana Janková ²
Authors‘ workplace: III. interní klinika – nefrologická, revmatologická a endokrinologická, FN a LF UP Olomouc ¹; Ústav klinické a molekulární patologie, LF UP Olomouc ²
Published in: Vnitř Lék 2021; 67(1): 58-61
Category: Case Reports

Overview

Incidence of ANCA antibodies in patients with systemic lupus erythematosus (SLE) is described in 24–31 %, but they are not related to the distribution and severity of organ involvement in SLE; the routine monitoring is not recommended. Overlap syndrome of systemic lupus erythematosus and ANCA associated vasculitis (AAV) is rare. The difficult diagnosis and treatment of this syndrome is described in this case report of the patient with SLE and severe kidney involvement resulting from AAV.

Keywords:

ANCA associated vasculitis – overlap syndrome – systemic lupus erythematosus.

Sources

1. Devrimsel G, Serdaroglu Beyazal M. Three Case Reports of Rhupus Syndrome: An Overlap Syndrome of Rheumatoid Arthritis and Systemic Lupus Erythematosus. Case Rep Rheumatol. 2018;2018:6194738. Published 2018 Jan 21. doi: 10.1155/2018/6194738

2. AlFadhli S., Nizam R. Rhupus: a crosswalk between lupus and rheumatoid arthritis. OA Arthritis. 2014; 2(1): p. 3.

3. Lockshin MD, Levine AB, Erkan D. Patients with overlap autoimmunedisease differ from those with‘pure’ disease. Lupus Science & Medicine 2015; 2: e000084. doi: 10.1136/ lupus-2015-000084.

4. Jarrot PA, Chiche L, Hervier B et al. Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody‑Associated Vasculitis Overlap Syndrome in Patients With Biopsy‑Proven Glomerulonephritis. Medicine (Baltimore).2016; 95(22): e3748. doi: 10.1097/ MD.0000000000003748.

5. Hervier B, Hamidou M, Haroche J et al. Systemic lupus erythematosus associated with ANCA‑associated vasculitis: an overlapping syndrome? Rheumatol Int. 2012 Oct; 32(10): 3285-3290. Epub 2011 Jul 30.

6. Farshad S, Kanaan C, Savedchuk S et al. Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review. Case Rep Rheumatol. 2019 Dec 14; 2019: 8750306. doi: 10.1155/2019/8750306. eCollection 2019.

7. Petri M, Orbai AM, Alarcón GS et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64(8): 2677-2686. doi: 10.1002/art.34473.

8. Aringer M, Costenbader K, Daikh D et al. 2019 European League Against Rheumatism/ American College of Rheumatology Classification Criteria for Systemic Lupus Erythema‑ tosus. Arthritis Rheumatol. 2019; 71(9): 1400–1412. doi: 10.1002/art.40930. Epub 2019 Aug 6.

9. Merkel PA, Polisson RP, Chang Y et al. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med. 1997; 126(11): 866–873.

10. Fauzi AR, Kong NC, Chua MK et al. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system asso‑ ciations. Med J Malaysia. 2004; 59(3): 372–377.

11. Pradhan VD, Badakere SS, Bichile LS et al. Anti‑neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India. 2004; 52: 533–537.

12. Olson SW, Lee JJ, Poirier M et al. Anti‑Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis. Autoimmune, DiS. 2017; 2017: 1872846. doi: 10.1155/2017/1872846. Epub 2017 Dec 24.

13. Wang S, Shang J, Xiao J et al. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody. Ren Fail. 2020; 42(1): 244–254. doi: 10.1080/0886022X.2020.1735416.

14. Koh JH, Kemna MJ, Cohen Tervaert JW et al. Can an increase in anti‑neutrophil cytoplasmic autoantibody titer predict relapses in anti‑neutrophil cytoplasmic antibody asso‑ ciated vasculitis? Arthritis Rheum 2016; 68: 1571–1573.

15. Kitching AR, Anders HJ, Basu N et al. ANCA‑associated vasculitis. Nat Rev Dis Primers. 2020; 6(1): 71. Published 2020 Aug 27. doi:10.1038/s41572-020-0204-y

16. Jesmin T, Roy RR, Anjum MF, Akter M. Anti‑neutrophil cytoplasmic antibodies in systemic lupus erythematosus and lupus nephritis: an overlapping syndrome. IOSR Journal of Dental and Medical Sciences. 2017; 16(3): 6–8. doi: 10.9790/0853-1603050608.

17. Farah RI, Shahin NA, Alawneh M, Adwan M. Rapidly progressive glomerulonephritis due to systemic lupus erythematosus and ANCA‑associated vasculitis overlap. Lupus. 2020; 29(8): 983–986.

18. Itikyala S, Pattanaik D, Raza S. Systemic Lupus Erythematosus (SLE) and Antineutrophil Cytoplasmic Antibody‑Associated Vasculitis (AAV) Overlap Syndrome: Case Report and Review of the Literature. Case Rep Rheumatol. 2019; 2019: 5013904. doi: 10.1155/2019/5013904. eCollection 2019.

19. Curtiss P, Liebman T, Khorolsky C, Brinster N, Beasley J, Lo Sicco K. Systemic lupus erythematosus and antineutrophil cytoplasmic antibody‑associated vasculitis: an emer‑ ging overlap syndrome with cutaneous manifestations.

20. Fanouriakis A, Kostopoulou M, Alunno A et al 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases 2019; 78: 736–745.

21. Yates M, Watts RA, Bajema IM et al EULAR/ERA‑EDTA recommendations for the management of ANCA‑associated vasculitis Annals of the Rheumatic Diseases 2016; 75: 1583–1594.